Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. 1994

P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
First Medical Clinic, University of Bologna, S. Orsola Hospital, Italy.

OBJECTIVE To determine the concentrations of interleukin-1 beta, interleukin-6, and interleukin-8 in tissue homogenates of mucosal biopsy specimens from Helicobacter pylori-positive and -negative patients. METHODS In 43 consecutive patients who underwent upper gastrointestinal endoscopy, seven antral biopsies were taken; three specimens were used for cytokine determination and the remaining four biopsies were processed for H. pylori detection. Peripheral venous blood was collected and IgG to H. pylori was assayed by an ELISA technique. RESULTS Twenty-nine of 43 patients (67%) were histologically positive for H. pylori; all had chronic gastritis. The mucosal levels of interleukin-6 and interleukin-8 were significantly higher in H. pylori-positive patients than in the negative patients (p < 0.001). A significantly higher percentage of interleukin-8 was found in patients colonized by H. pylori with active superficial chronic gastritis (85.7%), compared to quiescent superficial gastritis (12.5%) (p < 0.01), and the median and range were, respectively, 400 (0-1000) and 0 (0-200) pg/mg protein (p < 0.001). In patients with active superficial gastritis, a significant correlation between interleukin-6 and -8 was found (p 0.01). No difference was found regarding the mucosal levels of interleukin-1 beta according to the presence of H. pylori. CONCLUSIONS These results suggest a possible pathogenetic role for interleukin-6 and interleukin-8 in H. pylori-associated gastritis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004415 Dyspepsia Impaired digestion, especially after eating. Indigestion,Dyspepsias,Indigestions
D005260 Female Females
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005756 Gastritis Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders. Gastritides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
October 1998, Infection and immunity,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
October 1998, Journal of gastroenterology,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
June 2001, Helicobacter,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
April 1993, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
December 1994, European journal of gastroenterology & hepatology,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
February 2004, Mediators of inflammation,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
July 1999, Gut,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
December 2013, Microbial pathogenesis,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
February 1994, Journal of pediatric gastroenterology and nutrition,
P Gionchetti, and D Vaira, and M Campieri, and J Holton, and M Menegatti, and A Belluzzi, and E Bertinelli, and M Ferretti, and C Brignola, and M Miglioli
October 2016, Helicobacter,
Copied contents to your clipboard!